is glp 1 safe for kidneys Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection Ozempic and GLP-1 Drugs: Risk

Omzo's own Terms explicitly state the platform "makes no claims that its compounded formulations are equivalent to, have the same active ingredient as, or will produce the same clinical outcomes as FDA-approved drugs." The active ingredient overlaps

The search strategy included a combination of Medical Subject Headings (MeSH) and free-text terms related to GLP-1 receptor agonists (e.g., semaglutide, liraglutide, and GLP-1 agonist), obesity management, long-term efficacy, weight maintenance, and safety outcomes

Additionally, support beyond prescriptionwith continuous follow-ups and a responsive care teamis essential

Lin DSH, Lee JK, Hung CS, Chen WJ (2021) The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials